Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-(2-chloro-4-iodophenylamino)-n-3,4-difluorobenzoic Acid
2. Atr-002
3. Atr002
1. Zapnometinib
2. 303175-44-2
3. Zapnometinib [inn]
4. Pd-0184264
5. Atr-002
6. 4rzd8lk83v
7. Benzoic Acid, 2-[(2-chloro-4-iodophenyl)amino]-3,4-difluoro-
8. Unii-4rzd8lk83v
9. 2-(2-chloro-4-iodoanilino)-3,4-difluorobenzoic Acid
10. Atr002
11. Chembl481949
12. 2-((2-chloro-4-iodophenyl)amino)-3,4-difluorobenzoic Acid
13. 3,4-difluoro-2-((2-chloro-4-iodophenyl)amino)benzoic Acid
14. Benzoic Acid, 2-((2-chloro-4-iodophenyl)amino)-3,4-difluoro-
15. 2-[(2-chloro-4-iodophenyl)amino]-3,4-difluorobenzoic Acid
16. 3,4-difluoro-2-[(2-chloro-4-iodophenyl)amino]benzoic Acid
17. Zapnometinib [usan]
18. Schembl1488782
19. Atr 002 [who-dd]
20. Gtpl11679
21. Dtxsid80435811
22. Bcp31195
23. Ex-a7557
24. Bdbm50595935
25. Akos027447717
26. Ms-27054
27. Pd0184264; Atr-002
28. Hy-139558
29. Pd0184264
30. Cs-0204157
31. Ft-0664738
32. F77040
33. J-017908
34. 3,4-difluoro-2-(2-chloro-4-iodophenylamino)-benzoic Acid
Molecular Weight | 409.55 g/mol |
---|---|
Molecular Formula | C13H7ClF2INO2 |
XLogP3 | 5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 49.3 |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 363 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
96
PharmaCompass offers a list of zapnometinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right zapnometinib manufacturer or zapnometinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred zapnometinib manufacturer or zapnometinib supplier.
PharmaCompass also assists you with knowing the zapnometinib API Price utilized in the formulation of products. zapnometinib API Price is not always fixed or binding as the zapnometinib Price is obtained through a variety of data sources. The zapnometinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A zapnometinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of zapnometinib, including repackagers and relabelers. The FDA regulates zapnometinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. zapnometinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A zapnometinib supplier is an individual or a company that provides zapnometinib active pharmaceutical ingredient (API) or zapnometinib finished formulations upon request. The zapnometinib suppliers may include zapnometinib API manufacturers, exporters, distributors and traders.
zapnometinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of zapnometinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right zapnometinib GMP manufacturer or zapnometinib GMP API supplier for your needs.
A zapnometinib CoA (Certificate of Analysis) is a formal document that attests to zapnometinib's compliance with zapnometinib specifications and serves as a tool for batch-level quality control.
zapnometinib CoA mostly includes findings from lab analyses of a specific batch. For each zapnometinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
zapnometinib may be tested according to a variety of international standards, such as European Pharmacopoeia (zapnometinib EP), zapnometinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (zapnometinib USP).